Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Huntington Bancshares
HBAN
|
$217M |
| 2 |
Amazon
AMZN
|
$170M |
| 3 |
Microsoft
MSFT
|
$140M |
| 4 |
Apple
AAPL
|
$140M |
| 5 |
Bristol-Myers Squibb
BMY
|
$138M |
Top Sells
| 1 |
TCF
TCF Financial Corporation Common Stock
TCF
|
$302M |
| 2 |
CTB
Cooper Tire & Rubber Co.
CTB
|
$212M |
| 3 |
Ford
F
|
$202M |
| 4 |
Booking.com
BKNG
|
$159M |
| 5 |
JPMorgan Chase
JPM
|
$138M |
Sector Composition
| 1 | Financials | 17.39% |
| 2 | Technology | 16.04% |
| 3 | Industrials | 12.79% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Healthcare | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Sabre
SABR
$675M
| $242K | ﹤0.01% |
19,425
-1,318,381
| -99% | -$16.4M |
|
|
SELF
3302
Global Self Storage
SELF
$59.5M
| $241K | ﹤0.01% |
46,170
| – | – |
|
3303
Pathfinder Bancorp
PBHC
$92.5M
| $240K | ﹤0.01% |
15,182
+705
| +5% | +$11.1K |
|
3304
Ranger Energy Services
RNGR
$309M
| $239K | ﹤0.01% |
29,858
+24
| +0.1% | +$192 |
|
3305
Neuronetics
STIM
$214M
| $239K | ﹤0.01% |
14,933
-2,409
| -14% | -$38.6K |
|
|
OSH
3306
DELISTED
Oak Street Health, Inc.
OSH
| $237K | ﹤0.01% |
+4,047
| New | +$237K |
|
|
ARD
3307
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $237K | ﹤0.01% |
9,658
+655
| +7% | +$16.1K |
|
3308
NextDecade
NEXT
$2.8B
| $234K | ﹤0.01% |
56,664
+13,629
| +32% | +$56.3K |
|
|
AMTBB
3309
DELISTED
Amerant Bancorp Inc. Class B Common Stock
AMTBB
| $234K | ﹤0.01% |
11,969
+315
| +3% | +$6.16K |
|
3310
Solid Biosciences
SLDB
$428M
| $232K | ﹤0.01% |
4,231
-764
| -15% | -$41.9K |
|
|
STR
3311
DELISTED
Sitio Royalties
STR
| $231K | ﹤0.01% |
+11,381
| New | +$231K |
|
3312
Flexible Solutions
FSI
$120M
| $228K | ﹤0.01% |
58,275
-1,623
| -3% | -$6.35K |
|
3313
Relay Therapeutics
RLAY
$710M
| $228K | ﹤0.01% |
6,236
| – | – |
|
3314
Q32 Bio
QTTB
$20.4M
| $228K | ﹤0.01% |
1,741
-2,092
| -55% | -$274K |
|
3315
BRF SA
BRFS
$5.86B
| $227K | ﹤0.01% |
41,538
| – | – |
|
|
UBX
3316
DELISTED
Unity Biotechnology
UBX
| $227K | ﹤0.01% |
4,900
+34
| +0.7% | +$1.58K |
|
3317
Affinity Bancshares
AFBI
$123M
| $226K | ﹤0.01% |
17,572
-10,769
| -38% | -$139K |
|
3318
SELLAS Life Sciences
SLS
$201M
| $226K | ﹤0.01% |
20,320
+4,911
| +32% | +$54.6K |
|
|
ESBK
3319
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $225K | ﹤0.01% |
15,723
+727
| +5% | +$10.4K |
|
3320
ADMA Biologics
ADMA
$4.03B
| $223K | ﹤0.01% |
139,313
-12,400
| -8% | -$19.8K |
|
3321
Santander
BSBR
$40.6B
| $222K | ﹤0.01% |
28,292
| – | – |
|
|
CELL
3322
DELISTED
PhenomeX Inc. Common Stock
CELL
| $222K | ﹤0.01% |
4,952
| – | – |
|
3323
NovaGold Resources
NG
$2.75B
| $219K | ﹤0.01% |
27,300
| – | – |
|
|
MYND
3324
Mynd.ai
MYND
$25.9M
| $218K | ﹤0.01% |
5,014
+2,627
| +110% | +$114K |
|
3325
Genmab
GMAB
$16.9B
| $216K | ﹤0.01% |
+5,282
| New | +$216K |
|